TY - JOUR
T1 - Adherence to ACIP Recommendation for Human Papillomavirus Vaccine Among US Adolescent Girls
AU - Rahman, Mahbubur
AU - Hirth, Jacqueline M.
AU - Berenson, Abbey B.
N1 - Funding Information:
Dr. Hirth is supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women’s Health Program—BIRCWH, PI: Berenson) from the Office of Research on Women’s Health (ORWH), the Office of the Director (OD), the National Institute of Allergy and Infectious Diseases (NIAID), and NICHD at the National Institutes of Health.
Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - The objective of this study was to examine correlates of human papillomavirus (HPV) vaccine use according to Advisory Committee on Immunization Practices (ACIP)’s recommendations among US adolescent girls. We used National Immunization Survey of Teens 2013 data. Based on provider-verified (n = 9403) information, 57.3, 39.1 and 19.0 % of adolescent girls, initiated, completed and completed the HPV vaccine according to ACIP’s recommendation (by age 12), respectively. Hispanic race/ethnicity, a physician recommendation for HPV vaccine and ≥1 influenza vaccine in the past 3 years were all associated with a higher likelihood of compliance with ACIP’s recommendation. Girls from a larger family and those whose immunization provider was a STD/school/teen clinic were less likely to receive the vaccine at the recommended age compared to a girl raised in a smaller sized family and received immunization from a hospital facility, respectively. Only one-fifth of 13–17 yo girls receive the HPV vaccine by age 12 as recommended by ACIP. Physician visits and influenza vaccination settings are opportunities to improve vaccine series completion at the recommended age.
AB - The objective of this study was to examine correlates of human papillomavirus (HPV) vaccine use according to Advisory Committee on Immunization Practices (ACIP)’s recommendations among US adolescent girls. We used National Immunization Survey of Teens 2013 data. Based on provider-verified (n = 9403) information, 57.3, 39.1 and 19.0 % of adolescent girls, initiated, completed and completed the HPV vaccine according to ACIP’s recommendation (by age 12), respectively. Hispanic race/ethnicity, a physician recommendation for HPV vaccine and ≥1 influenza vaccine in the past 3 years were all associated with a higher likelihood of compliance with ACIP’s recommendation. Girls from a larger family and those whose immunization provider was a STD/school/teen clinic were less likely to receive the vaccine at the recommended age compared to a girl raised in a smaller sized family and received immunization from a hospital facility, respectively. Only one-fifth of 13–17 yo girls receive the HPV vaccine by age 12 as recommended by ACIP. Physician visits and influenza vaccination settings are opportunities to improve vaccine series completion at the recommended age.
KW - Advisory Committee on Immunization Practices
KW - Human papillomavirus
KW - Vaccine completion
KW - Vaccine initiation
UR - http://www.scopus.com/inward/record.url?scp=84990842318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84990842318&partnerID=8YFLogxK
U2 - 10.1007/s10900-016-0267-6
DO - 10.1007/s10900-016-0267-6
M3 - Article
C2 - 27704304
AN - SCOPUS:84990842318
SN - 0094-5145
VL - 42
SP - 385
EP - 389
JO - Journal of Community Health
JF - Journal of Community Health
IS - 2
ER -